International Medical Journal, Vol. 21., Iss. 4, 2015, P. 5−12.
CONGRESS OF THE EUROPEAN SOCIETY OF CARDIOLOGY (LONDON, 2015): RESULTS OF THE MOST IMPORTANT CLINICAL TRIALS
Kuban State Medical University, Ministry of Health of Russian Federation, Krasnodar, Russian Federation
A report on the six scientific sessions Hotline of Congress of the European Society of Cardiology (2015) dedicated to the general topic «Environment and heart» is presented. The highest interest of the Congress participants was attracted by the results of 28 specially selected research. The tactics of biochemical diagnosis of myocardial infarction, the problem of early detection and treatment of cardiac remodeling, the effectiveness of cyclosporine were presented at Session 1 «Acute myocardial infarction». The ways to reduce the risk of atrial fibrillation recurrence were discussed at Session 2 «Atrial fibrillation/pacing». Session 3 «Diabetes/pharmacology» evaluated cardiovascular safety of sitagliptin, the effectiveness of prolonged dual antiplatelet therapy in patients with type 2 diabetes mellitus with concomitant cardiovascular disease. The subject at Session 4 «Hypertension» was treatment (Telmisartan, Spironolactone, Amiloride, and others) of patients with hypertension and at least one risk factor for cardiovascular complications. Session 5 «Heart failure» examined research results, which define the role of early detection of fluid retention in the lungs, effectiveness of percutaneous intracoronary gene delivery at sarcoplasmic reticulum calcium ATPase deficiency, diagnosis and treatment of Chavez' disease. A new non−invasive technique for measuring fractional flow reserve using computed tomography was presented at Session 6 «Coronary artery disease».
Key words: cardiovascular diseases, clinical trials, Hot Line sessions.